Clinical utility of emerging biomarkers in prostate cancer liquid biopsies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical utility of emerging biomarkers in prostate cancer liquid biopsies

Published:2019-10-11 Issue:2 Volume:20 Page:219-230
ISSN:1473-7159
Container-title:Expert Review of Molecular Diagnostics
language:en
Short-container-title:Expert Review of Molecular Diagnostics

Author:

Boerrigter Emmy¹,Groen Levi N.²,Van Erp Nielka P.¹,Verhaegh Gerald W.²,Schalken Jack A.²

Affiliation:

1. Department of Pharmacy, Radboud Institute for Health Sciences, Radboud university medical center, Nijmegen, The Netherlands

2. Department of Experimental Urology, Radboud Institute for Molecular Life Sciences, Radboud university medical center, Nijmegen, The Netherlands

Publisher

Informa UK Limited

Subject

Genetics,Molecular Biology,Molecular Medicine,Pathology and Forensic Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737159.2019.1675515

Reference112 articles.

1. Abiraterone and Increased Survival in Metastatic Prostate Cancer

2. Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy

3. Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy

4. Enzalutamide in Metastatic Prostate Cancer before Chemotherapy

5. Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SERPINH1 modulates apoptosis by inhibiting P62 ubiquitination degradation to promote bone metastasis of prostate cancer;iScience;2024-08

2. Clinical Implementation of a Noninvasive, Multi-Analyte Droplet Digital PCR Test to Screen for Androgen Receptor Alterations;The Journal of Molecular Diagnostics;2024-06

3. Prospects of liquid biopsy in the prognosis and clinical management of gastrointestinal cancers;Frontiers in Molecular Biosciences;2024-05-06

4. Pretreatment level of serum sialic acid predicts both qualitative and quantitative bone metastases of prostate cancer;Frontiers in Endocrinology;2024-02-07

5. Molecular biomarkers in prostate cancer tumorigenesis and clinical relevance;Critical Reviews in Oncology/Hematology;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3